RUNX super-enhancer control through the Notch pathway by Epstein-Barr virus transcription factors regulates B cell growth

Nucleic Acids Research

Volumn 44, Issue 10, 2016, Pages 4636-4650

  Gunnell, Andrea ^a   Webb, Helen M ^a   Wood, C David ^a   McClellan, Michael J ^a,f   Wichaidit, Billy ^a   Kempkes, Bettina ^b   Jenner, Richard G ^c   Osborne, Cameron ^d   Farrell, Paul J ^e   West, Michelle J ^a  

^a UNIVERSITY OF SUSSEX   (United Kingdom)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d GUY S HOSPITAL   (United Kingdom)

^e Virology Section   (United Kingdom)

^f UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EPSTEIN BARR VIRUS ANTIGEN; EPSTEIN BARR VIRUS ANTIGEN 2; EPSTEIN BARR VIRUS ANTIGEN 3B; EPSTEIN BARR VIRUS ANTIGEN 3C; NOTCH RECEPTOR; TRANSCRIPTION FACTOR RUNX; TRANSCRIPTION FACTOR RUNX1; TRANSCRIPTION FACTOR RUNX3; UNCLASSIFIED DRUG; EBNA-3A ANTIGEN; EBNA-3B ANTIGEN; EBNA4 ANTIGEN; IMMUNOGLOBULIN J RECOMBINATION SIGNAL SEQUENCE BINDING PROTEIN; RBPJ PROTEIN, HUMAN; RUNX1 PROTEIN, HUMAN; RUNX3 PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

ARTICLE; B LYMPHOCYTE; CELL GROWTH; CELL SPECIFICITY; CELLS BY BODY ANATOMY; CONTROLLED STUDY; ENHANCER REGION; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; GENE ACTIVATION; GENE CONTROL; GENE EXPRESSION; GROWTH INHIBITION; GROWTH REGULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; RUNX GENE; RUNX1 GENE; RUNX3 GENE; VIRUS CELL INTERACTION; CELL LINE; GENETICS; HUMAN; METABOLISM; TRANSCRIPTION INITIATION; VIROLOGY;

B-LYMPHOCYTES; CELL LINE; CORE BINDING FACTOR ALPHA 2 SUBUNIT; CORE BINDING FACTOR ALPHA 3 SUBUNIT; CORE BINDING FACTOR ALPHA SUBUNITS; ENHANCER ELEMENTS, GENETIC; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; HUMANS; IMMUNOGLOBULIN J RECOMBINATION SIGNAL SEQUENCE-BINDING PROTEIN; RECEPTORS, NOTCH; TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ACTIVATION;

EID: 84973457787     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkw085     Document Type: Article

References (64)

1. Ito, Y., Bae, S. C., Chuang, L. S. (2015) The RUNX family: developmental regulators in cancer. Nat. Rev. Cancer, 15, 81-95.
2. Chuang, L. S., Ito, K., Ito, Y. (2013) RUNX family: regulation and diversification of roles through interacting proteins. Int. J. Cancer, 132, 1260-1271.
3. Tahirov, T. H., Inoue-Bungo, T., Morii, H., Fujikawa, A., Sasaki, M., Kimura, K., Shiina, M., Sato, K., Kumasaka, T., Yamamoto, M. et al. (2001) Structural analyses of DNA recognition by the AML1/Runx-1 Runt domain and its allosteric control by CBFbeta. Cell, 104, 755-767.
4. De Braekeleer, E., Douet-Guilbert, N., Morel, F., Le Bris, M. J., Ferec, C., De Braekeleer, M. (2011) RUNX1 translocations and fusion genes in malignant hemopathies. Future Oncol., 7, 77-91.
5. Martin, J. W., Zielenska, M., Stein, G. S., van Wijnen, A. J., Squire, J. A. (2011) The role of RUNX2 in Osteosarcoma Oncogenesis. Sarcoma, doi:10. 1155/2011/282745.
6. Nottingham, W. T., Jarratt, A., Burgess, M., Speck, C. L., Cheng, J. F., Prabhakar, S., Rubin, E. M., Li, P. S., Sloane-Stanley, J., Kong, A. S. J. et al. (2007) Runx1-mediated hematopoietic stem-cell emergence is controlled by a Gata/Ets/SCL-regulated enhancer. Blood, 110, 4188-4197.
7. Markova, E. N., Kantidze, O. L., Razin, S. V. (2011) Transcriptional regulation and spatial organisation of the human AML1/RUNX1 gene. J. Cell. Biochem., 112, 1997-2005.
8. Kwiatkowski, N., Zhang, T., Rahl, P. B., Abraham, B. J., Reddy, J., Ficarro, S. B., Dastur, A., Amzallag, A., Ramaswamy, S., Tesar, B. et al. (2014) Targeting transcription regulation in cancer with a covalent CDK7 inhibitor. Nature, 511, 616-620.
9. Saha, A., Robertson, E. S. (2011) Epstein-Barr virus-associated B-cell lymphomas: pathogenesis and clinical outcomes. Clin. Cancer Res., 17, 3056-3063.
10. Nilsson, K., Klein, G., Henle, W., Henle, G. (1971) The establishment of lymphoblastoid lines from adult and fetal human lymphoid tissue and its dependence on EBV. Int. J. Cancer, 8, 443-450.
11. White, R. E., Groves, I. J., Turro, E., Yee, J., Kremmer, E., Allday, M. J. (2010) Extensive co-operation between the Epstein-Barr virus EBNA3 proteins in the manipulation of host gene expression and epigenetic chromatin modification. PLoS One, 5, e13979.
12. Kaiser, C., Laux, G., Eick, D., Jochner, N., Bornkamm, G. W., Kempkes, B. (1999) The proto-oncogene c-myc is a direct target gene of Epstein-Barr virus nuclear antigen 2. J. Virol., 73, 4481-4484.
13. 13., erton, E., Yee, J., Smith, P., Crook, T., White, R. E., Allday, M. J. (2008) Two Epstein-Barr virus (EBV) oncoproteins cooperate to repress expression of the proapoptotic tumour-suppressor Bim: clues to the pathogenesis of Burkitt's lymphoma. Oncogene, 27, 421-433.
14. Skalska, L., White, R. E., Franz, M., Ruhmann, M., Allday, M. J. (2010) Epigenetic repression of p16(INK4A) by latent Epstein-Barr virus requires the interaction of EBNA3A and EBNA3C with CtBP. PLoS Pathog., 6, e1000951.
15. McClellan, M. J., Khasnis, S., Wood, C. D., Palermo, R. D., Schlick, S. N., Kanhere, A. S., Jenner, R. G., West, M. J. (2012) Downregulation of integrin receptor-signaling genes by Epstein-Barr virus EBNA 3C via promoter-proximal and-distal binding elements. J. Virol., 86, 5165-5178.
16. McClellan, M. J., Wood, C. D., Ojeniyi, O., Cooper, T. J., Kanhere, A., Arvey, A., Webb, H. M., Palermo, R. D., Harth-Hertle, M. L., Kempkes, B. et al. (2013) Modulation of enhancer looping and differential gene targeting by Epstein-Barr virus transcription factors directs cellular reprogramming. PLoS Pathog., 9, e1003636.
17. Waltzer, L., Logeat, F., Brou, C., Israel, A., Sergeant, A., Manet, E. (1994) The human J kappa recombination signal sequence binding protein (RBP-J kappa) targets the Epstein-Barr virus EBNA2 protein to its DNA responsive elements. EMBO J., 13, 5633-5638.
18. Waltzer, L., Perricaudet, M., Sergeant, A., Manet, E. (1996) Epstein-Barr virus EBNA3A and EBNA3C proteins both repress RBP-J kappa-EBNA2-activated transcription by inhibiting the binding of RBP-J kappa to DNA. J. Virol., 70, 5909-5915.
19. Grossman, S. R., Johannsen, E., Tong, X., Yalamanchili, R., Kieff, E. (1994) The Epstein-Barr virus nuclear antigen 2 transactivator is directed to response elements by the J kappa recombination signal binding protein. Proc. Natl. Acad. Sci. U. S. A., 91, 7568-7572.
20. Zimber-Strobl, U., Strobl, L. J., Meitinger, C., Hinrichs, R., Sakai, T., Furukawa, T., Honjo, T., Bornkamm, G. W. (1994) Epstein-Barr virus nuclear antigen 2 exerts its transactivating function through interaction with recombination signal binding protein RBP-J kappa, the homologue of Drosophila Suppressor of Hairless. EMBO J., 13, 4973-4982.
21. Robertson, E. S., Lin, J., Kieff, E. (1996) The amino-terminal domains of Epstein-Barr virus nuclear proteins 3A, 3B, 3C interact with RBPJ(kappa). J. Virol., 70, 3068-3074.
22. Yalamanchili, R., Tong, X., Grossman, S., Johannsen, E., Mosialos, G., Kieff, E. (1994) Genetic and biochemical evidence that EBNA 2 interaction with a 63-kDa cellular GTG-binding protein is essential for B lymphocyte growth transformation by EBV. Virology, 204, 634-641.
23. Maruo, S., Johannsen, E., Illanes, D., Cooper, A., Zhao, B., Kieff, E. (2005) Epstein-Barr virus nuclear protein 3A domains essential for growth of lymphoblasts: transcriptional regulation through RBP-Jkappa/CBF1 is critical. J. Virol., 79, 10171-10179.
24. Maruo, S., Wu, Y., Ito, T., Kanda, T., Kieff, E. D., Takada, K. (2009) Epstein-Barr virus nuclear protein EBNA3C residues critical for maintaining lymphoblastoid cell growth. Proc. Natl. Acad. Sci. U. S. A., 106, 4419-4424.
25. Johannsen, E., Miller, C. L., Grossman, S. R., Kieff, E. (1996) EBNA-2 and EBNA-3C extensively and mutually exclusively associate with RBPJkappa in Epstein-Barr virus-transformed B lymphocytes. J. Virol., 70, 4179-4183.
26. Zhao, B., Marshall, D. R., Sample, C. E. (1996) A conserved domain of the Epstein-Barr virus nuclear antigens 3A and 3C binds to a discrete domain of Jkappa. J. Virol., 70, 4228-4236.
27. Ling, P. D., Hayward, S. D. (1995) Contribution of conserved amino acids in mediating the interaction between EBNA2 and CBF1/RBPJk. J. Virol., 69, 1944-1950.
28. Johnson, S. E., Ilagan, M. X., Kopan, R., Barrick, D. (2010) Thermodynamic analysis of the CSL x Notch interaction: distribution of binding energy of the Notch RAM region to the CSL beta-trefoil domain and the mode of competition with the viral transactivator EBNA2. J. Biol. Chem., 285, 6681-6692.
29. Laux, G., Adam, B., Strobl, L. J., Moreau-Gachelin, F. (1994) The Spi-1/PU. 1 and Spi-B ets family transcription factors and the recombination signal binding protein RBP-J kappa interact with an Epstein-Barr virus nuclear antigen 2 responsive cis-element. EMBO J., 13, 5624-5632.
30. Johannsen, E., Koh, E., Mosialos, G., Tong, X., Kieff, E., Grossman, S. R. (1995) Epstein-Barr virus nuclear protein 2 transactivation of the latent membrane protein 1 promoter is mediated by J kappa and PU. 1. J. Virol., 69, 253-262.
31. Zhao, B., Sample, C. E. (2000) Epstein-barr virus nuclear antigen 3C activates the latent membrane protein 1 promoter in the presence of Epstein-Barr virus nuclear antigen 2 through sequences encompassing an spi-1/Spi-B binding site. J. Virol., 74, 5151-5160.
32. Tzellos, S., Correia, P. B., Karstegl, C. E., Cancian, L., Cano-Flanagan, J., McClellan, M. J., West, M. J., Farrell, P. J. (2014) A single amino acid in EBNA-2 determines superior B lymphoblastoid cell line growth maintenance by Epstein-Barr virus Type 1 EBNA-2. J. Virol., 88, 8743-8753.
33. Zhao, B., Zou, J., Wang, H., Johannsen, E., Peng, C. W., Quackenbush, J., Mar, J. C., Morton, C. C., Freedman, M. L., Blacklow, S. C. et al. (2011) Epstein-Barr virus exploits intrinsic B-lymphocyte transcription programs to achieve immortal cell growth. Proc. Natl. Acad. Sci. U. S. A., 108, 14902-14907.
34. Cohen, J. I. (1992) A region of herpes simplex virus VP16 can substitute for a transforming domain of Epstein-Barr virus nuclear protein 2. Proc. Natl. Acad. Sci. U. S. A., 89, 8030-8034.
35. Maier, S., Staffler, G., Hartmann, A., Hock, J., Henning, K., Grabusic, K., Mailhammer, R., Hoffmann, R., Wilmanns, M., Lang, R. et al. (2006) Cellular target genes of Epstein-Barr virus nuclear antigen 2. J. Virol., 80, 9761-9771.
36. Jochner, N., Eick, D., Zimber-Strobl, U., Pawlita, M., Bornkamm, G. W., Kempkes, B. (1996) Epstein-Barr virus nuclear antigen 2 is a transcriptional suppressor of the immunoglobulin mu gene: implications for the expression of the translocated c-myc gene in Burkitt's lymphoma cells. EMBO J., 15, 375-382.
37. Paschos, K., Smith, P.,erton, E., Middeldorp, J. M., White, R. E., Allday, M. J. (2009) Epstein-barr virus latency in B cells leads to epigenetic repression and CpG methylation of the tumour suppressor gene Bim. PLoS Pathog., 5, e1000492.
38. Schmidt, S. C., Jiang, S., Zhou, H., Willox, B., Holthaus, A. M., Kharchenko, P. V., Johannsen, E. C., Kieff, E., Zhao, B. (2015) Epstein-Barr virus nuclear antigen 3A partially coincides with EBNA3C genome-wide and is tethered to DNA through BATF complexes. Proc. Natl. Acad. Sci. U. S. A., 112, 554-559.
39. Jiang, S., Willox, B., Zhou, H., Holthaus, A. M., Wang, A., Shi, T. T., Maruo, S., Kharchenko, P. V., Johannsen, E. C., Kieff, E. et al. (2014) Epstein-Barr Virus Nuclear Antigen 3C binds to BATF/IRF4 or SPI1/IRF4 composite sites and recruits Sin3A to repress CDKN2A. Proc. Natl. Acad. Sci. U. S. A., 111, 421-426.
40. Ben-Bassat, H., Goldblum, N., Mitrani, S., Goldblum, T., Yoffey, J. M., Cohen, M. M., Bentwich, Z., Ramot, B., Klein, E., Klein, G. (1977) Establishment in continuous culture of a new type of lymphocyte from a "Burkitt like" malignant lymphoma (line D. G.-75). Int. J. Cancer, 19, 27-33.
41. Maier, S., Santak, M., Mantik, A., Grabusic, K., Kremmer, E., Hammerschmidt, W., Kempkes, B. (2005) A somatic knockout of CBF1 in a human B-cell line reveals that induction of CD21 and CCR7 by EBNA-2 is strictly CBF1 dependent and that downregulation of immunoglobulin M is partially CBF1 independent. J. Virol., 79, 8784-8792.
42. Gregory, C. D., Rowe, M., Rickinson, A. B. (1990) Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line. J. Gen. Virol., 71, 1481-1495.
43. Palermo, R. D., Webb, H. M., West, M. J. (2011) RNA polymerase II stalling promotes nucleosome occlusion and pTEFb recruitment to drive immortalization by Epstein-Barr virus. PLoS Pathog., 7, e1002334.
44. Spender, L. C., Whiteman, H. J., Karstegl, C. E., Farrell, P. J. (2005) Transcriptional cross-regulation of RUNX1 by RUNX3 in human B cells. Oncogene, 24, 1873-1881.
45. West, M. J., Webb, H. M., Sinclair, A. J., Woolfson, D. N. (2004) Biophysical and mutational analysis of the putative bZIP domain of Epstein-Barr virus EBNA 3C. J. Virol., 78, 9431-9445.
46. Bark-Jones, S. J., Webb, H. M., West, M. J. (2006) EBV EBNA 2 stimulates CDK9-dependent transcription and RNA polymerase II phosphorylation on serine 5. Oncogene, 25, 1775-1785.
47. Mifsud, B., Tavares-Cadete, F., Young, A. N., Sugar, R., Schoenfelder, S., Ferreira, L., Wingett, S. W.,rews, S., Grey, W., Ewels, P. A. et al. (2015) Mapping long-range promoter contacts in human cells with high-resolution capture Hi-C. Nat. Genet., 47, 598-606.
48. Khan, A., Zhang, X. (2016) dbSUPER: a database of super-enhancers in mouse and human genome. Nucleic Acids Res., 44, D164-D171.
49. Zhou, H., Schmidt, S. C., Jiang, S., Willox, B., Bernhardt, K., Liang, J., Johannsen, E. C., Kharchenko, P., Gewurz, B. E., Kieff, E. et al. (2015) Epstein-Barr virus oncoprotein super-enhancers control B cell growth. Cell Host Microbe, 17, 205-216.
50. Waltzer, L., Bourillot, P. Y., Sergeant, A., Manet, E. (1995) RBP-J kappa repression activity is mediated by a co-repressor and antagonized by the Epstein-Barr virus transcription factor EBNA2. Nucleic Acids Res., 23, 4939-4945.
51. Spender, L. C., Cornish, G. H., Sullivan, A., Farrell, P. J. (2002) Expression of transcription factor AML-2 (RUNX3, CBF(alpha)-3) is induced by Epstein-Barr virus EBNA-2 and correlates with the B-cell activation phenotype. J. Virol., 76, 4919-4927.
52. Hertle, M. L., Popp, C., Petermann, S., Maier, S., Kremmer, E., Lang, R., Mages, J., Kempkes, B. (2009) Differential gene expression patterns of EBV infected EBNA-3A positive and negative human B lymphocytes. PLoS Pathog., 5, e1000506.
53. Harth-Hertle, M. L., Scholz, B. A., Erhard, F., Glaser, L. V., Dolken, L., Zimmer, R., Kempkes, B. (2013) Inactivation of intergenic enhancers by EBNA3A initiates and maintains polycomb signatures across a chromatin domain encoding CXCL10 and CXCL9. PLoS Pathog., 9, e1003638.
54. Wang, A., Welch, R., Zhao, B., Ta, T., Keles, S., Johannsen, E. (2015) EBNA3 proteins regulate EBNA2 binding to distinct RBPJ genomic sites. J. Virol., doi:10. 1128/JVI. 02737-02715.
55. Whyte, W. A., Orlando, D. A., Hnisz, D., Abraham, B. J., Lin, C. Y., Kagey, M. H., Rahl, P. B., Lee, T. I., Young, R. A. (2013) Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell, 153, 307-319.
56. Soufi, A., Garcia, M. F., Jaroszewicz, A., Osman, N., Pellegrini, M., Zaret, K. S. (2015) Pioneer transcription factors target partial DNA motifs on nucleosomes to initiate reprogramming. Cell, 161, 555-568.
57. Lee, S., Sakakibara, S., Maruo, S., Zhao, B., Calderwood, M. A., Holthaus, A. M., Lai, C. Y., Takada, K., Kieff, E., Johannsen, E. (2009) Epstein-Barr virus nuclear protein 3C domains necessary for lymphoblastoid cell growth: interaction with RBP-Jkappa regulates TCL1. J. Virol., 83, 12368-12377.
58. Chen, A., Divisconte, M., Jiang, X., Quink, C., Wang, F. (2005) Epstein-Barr virus with the latent infection nuclear antigen 3B completely deleted is still competent for B-cell growth transformation in vitro. J. Virol., 79, 4506-4509.
59. White, R. E., Ramer, P. C., Naresh, K. N., Meixlsperger, S., Pinaud, L., Rooney, C., Savoldo, B., Coutinho, R., Bodor, C., Gribben, J. et al. (2012) EBNA3B-deficient EBV promotes B cell lymphomagenesis in humanized mice and is found in human tumors. J. Clin. Invest., 122, 1487-1502.
60. Lebestky, T., Jung, S. H., Banerjee, U. (2003) A Serrate-expressing signaling center controls Drosophila hematopoiesis. Genes Dev., 17, 348-353.
61. Nakagawa, M., Ichikawa, M., Kumano, K., Goyama, S., Kawazu, M., Asai, T., Ogawa, S., Kurokawa, M., Chiba, S. (2006) AML1/Runx1 rescues Notch1-null mutation-induced deficiency of para-aortic splanchnopleural hematopoiesis. Blood, 108, 3329-3334.
62. Burns, C. E., Traver, D., Mayhall, E., Shepard, J. L., Zon, L. I. (2005) Hematopoietic stem cell fate is established by the Notch-Runx pathway. Genes Dev., 19, 2331-2342.
63. Meier-Stiegen, F., Schwanbeck, R., Bernoth, K., Martini, S., Hieronymus, T., Ruau, D., Zenke, M., Just, U. (2010) Activated Notch1 target genes during embryonic cell differentiation depend on the cellular context and include lineage determinants and inhibitors. PLoS One, 5, e11481.
64. Fu, Y., Chang, A. C., Fournier, M., Chang, L., Niessen, K., Karsan, A. (2011) RUNX3 maintains the mesenchymal phenotype after termination of the Notch signal. J. Biol. Chem., 286, 11803-11813.